555-563
Review Article
Anticoagulant effects of Idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials
Job Harenberg, Ingrid Jörg, Yvonne Vukojevic, Gerd Mikus and Christel Weiss
565-573
Review Article
Use of ACE inhibitors and risk of community-acquired pneumonia: a review
Petros I. Rafailidis, Dimitrios K. Matthaiou, Ioannis Varbobitis and Matthew E. Falagas
575-582
Clinical Trial
Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events
Luis Almeida, Todd B. Kashdan, Teresa Nunes, Rui Coelho and António Albino-Teixeira, et al.
583-587
Pharmacogenetics
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs
Katsuyoshi Sugimoto, Tsukasa Uno and Tomonori Tateishi
589-597
Pharmacogenetics
Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects
Kyoung-Ah Kim, Pil-Whan Park and Ji-Young Park
599-603
Pharmacokinetics and Disposition
Population pharmacokinetics of arbekacin in burn patients
Jong Hyun Kim, Hyon-oh Lah and Dong-Seok Yim
605-609
Pharmacokinetics and Disposition
The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects
Takeshi Kadokura, Martin den Adel, Walter J. J. Krauwinkel, Tetsuo Takeshige and Akito Nishida
611-617
Pharmacoepidemiology and Prescription
The DEC-net European register of paediatric drug therapy trials: contents and context
Chiara Pandolfini, Maurizio Bonati, Valentina Rossi, Eugenio Santoro and Imti Choonara, et al.
619-625
Pharmacoepidemiology and Prescription
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision
G. Trifirò, M. Alacqua, S. Corrao, S. Moretti and D. U. Tari, et al.
627-634
Pharmacoepidemiology and Prescription
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction
Alejandro Macchia, Simona Monte, Fabio Pellegrini, Marilena Romero and Daniel Ferrante, et al.
635-639
Short Communication
Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women
In reference to pharmacovigilance
Philippe Mougenot, Olivier Lidove, Catherine Caillaud, Philippe Arnaud and Thomas Papo
641-646
Letter to the Editors
Open AccessShould medical students learn to develop a personal formulary?
An international, multicentre, randomised controlled study
T. P. G. M. De Vries, J. M. A. Daniels, C. W. Mulder, O. A. Groot and L. Wewerinke, et al.
647-648
Letter to the Editors
Tizanidine-induced hypotension in patients with liver cirrhosis
Kenji Momo, Masato Homma, Makoto Abei, Ichinosuke Hyodo and Yukinao Kohda